Drug Shortage Report for DEXTROSE INJECTION

Last updated on 2024-08-01 History
Report ID 223983
Drug Identification Number 02517132
Brand name DEXTROSE INJECTION
Common or Proper name DEXTROSE INJECTION
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) DEXTROSE
Strength(s) 50%
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 x 50mL vial / fiole
ATC code B05BA
ATC description I.V. SOLUTIONS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2024-04-01
Actual start date 2024-04-01
Estimated end date 2024-08-31
Actual end date 2024-07-31
Shortage status Resolved
Updated date 2024-08-01
Company comments Omega has made the decision to re-instate an allocation for Omega Dextrose to prevent overstocking of the Canadian labeled product.
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2024-08-01 French Compare
v12 2024-08-01 English Compare
v11 2024-07-23 French Compare
v10 2024-07-23 English Compare
v9 2024-07-02 French Compare
v8 2024-07-02 English Compare
v7 2024-06-04 French Compare
v6 2024-06-04 English Compare
v5 2024-04-02 English Compare
v4 2024-03-30 French Compare
v3 2024-03-30 English Compare
v2 2024-03-30 French Compare
v1 2024-03-30 English Compare

Showing 1 to 13 of 13